Profound Medical Corp. (PROF) Social Stream
PROFOUND MEDICAL CORP (PROF) Price Targets From Analysts
Use the tables below to see what analysts covering PROFOUND MEDICAL CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $30 | $26.25 | $28.062 | $7.68 | 265.39% |
| 2022-01-18 | 4 | $30.001 | $26.25 | $28.062 | $7.68 | 265.39% |
| 2022-03-04 | 4 | $30.001 | $23 | $26.812 | $7.68 | 249.11% |
| 2022-03-08 | 4 | $26.25 | $14 | $21.562 | $7.68 | 180.76% |
| 2022-03-18 | 4 | $26.25 | $14 | $21.312 | $7.68 | 177.5% |
| 2022-05-09 | 4 | $26.25 | $14 | $20.562 | $7.68 | 167.73% |
| 2022-05-10 | 4 | $22 | $14 | $17.5 | $7.68 | 127.86% |
| 2022-05-23 | 4 | $22 | $12 | $16.4 | $7.68 | 113.54% |
| 2022-07-18 | 4 | $20 | $12 | $15.5 | $7.68 | 101.82% |
| 2022-08-05 | 4 | $18 | $12 | $15.1 | $7.68 | 96.61% |
| 2022-09-28 | 4 | $18 | $12 | $14.6 | $7.68 | 90.1% |
| 2022-11-03 | 4 | $18 | $12 | $14.6 | $7.68 | 90.1% |
| 2022-11-07 | 4 | $15 | $6.5 | $12.375 | $7.68 | 61.13% |
| 2022-11-08 | 4 | $15 | $5.5 | $11 | $7.68 | 43.23% |
| 2023-01-06 | 4 | $15 | $5.5 | $11.5 | $7.68 | 49.74% |
| 2023-03-08 | 3 | $17 | $5.5 | $11.833 | $7.68 | 54.08% |
| 2023-03-21 | 3 | $17 | $6.5 | $12.583 | $7.68 | 63.84% |
| 2023-05-10 | 4 | $17 | $6.5 | $12.583 | $7.68 | 63.84% |
| 2023-05-15 | 4 | $18 | $6.5 | $13.5 | $7.68 | 75.78% |
| 2023-06-15 | 4 | $20 | $6.5 | $14.666 | $7.68 | 90.96% |
| 2023-08-04 | 4 | $20 | $11.5 | $16.208 | $7.68 | 111.04% |
| 2023-08-11 | 4 | $20 | $10 | $15.958 | $7.68 | 107.79% |
| 2023-09-18 | 4 | $20 | $10 | $15.958 | $7.68 | 107.79% |
| 2023-11-03 | 4 | $21 | $10 | $16.125 | $7.68 | 109.96% |
| 2023-11-04 | 3 | $21 | $9.5 | $15.35 | $7.68 | 99.87% |
| 2023-11-28 | 5 | $21 | $9.5 | $14.625 | $7.68 | 90.43% |
The Trend in the Analyst Price Target
PROF's average price target has moved up $0.03 over the prior 15 months.
Over the past 47 weeks, PROF's average upside potential has been 34.38%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-06 | 4 | 15 | 5.5 | 11.500 | 11.62 | -1.03% |
| 2023-03-08 | 3 | 17 | 5.5 | 11.833 | 10.78 | 9.77% |
| 2023-03-21 | 3 | 17 | 6.5 | 12.583 | 10.07 | 24.96% |
| 2023-11-03 | 3 | 21 | 9.5 | 15.650 | 9.60 | 63.02% |
| 2023-11-28 | 4 | 21 | 9.5 | 14.625 | 10.21 | 43.24% |
PROF Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
PROF's average broker recommendation rating worsened by 0.42 over the prior 21 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, PROFOUND MEDICAL CORP's number of analysts covering the stock is higher than 337.55% of them.
- In terms of how PROFOUND MEDICAL CORP fares relative to all US stocks, note that its average analyst price target is greater than 540.72% of that group.
- To contextualize these metrics, consider that out of all US stocks, PROFOUND MEDICAL CORP's upside potential (average analyst target price relative to current price) is greater than 2124.84% of them.
- In terms of how PROFOUND MEDICAL CORP fares relative to Medical Equipment stocks, note that its variance in analysts' estimates is lower than -1819.55% of that group.
Stocks similar to PROFOUND MEDICAL CORP in the Medical Equipment industry regarding analyst recommendations and price targets are RCEL, XAIR, and LQDA.
View All Top Stocks by Price Target
Make investment decisions regarding PROF using the data that counts. Try POWR Ratings for free.